"Multiple Sclerosis and Parkinson's Disease in the 21st Century," a daylong conference on the history, genetics and treatment of the progressive neurological disorders. It is sponsored by Teva Neuroscience with support from the Department of Neurology, Oregon Health & Science University School of Medicine; and the MS Center of Excellence-West and the Parkinson's Disease Research, Education & Clinical Center, Portland Veterans Affairs Medical Center.
Topics include: "Charcot, Multiple Sclerosis and Parkinson's Disease: A Historical Perspective"; "Neuroprotection and Parkinson's Disease"; "Neuroprotection and Multiple Sclerosis: The Future of Treatment of Progressive Disease"; "New Avenues in the Treatment of Multiple Sclerosis: The Coming of Age of Monoclonal Antibodies"; "Parkinson's Case Vignettes"; "Genes and MS: Tracking Down the Elusive Prey" -- John Whitaker Memorial Lecture; "Genetic Insights into Parkinson's Disease"; "Rehabilitation Medicine, MS and Parkinson's Disease: Tips for the Neurologist"; "Anxiety Busters: Update on the Treatment of Anxiety for the Neurologist"; "MS Case Vignettes."
event is geared toward MS and Parkinson's disease medical practitioners.
8 a.m. to 5 p.m. Friday, Sept. 17.
The Benson Hotel, 309 S.W. Broadway, Portland.
According to the National Multiple Sclerosis Society, about 400,000 Americans acknowledge having MS, and every week about 200 people are diagnosed. Two to three times as many women as men have the disease.
About 1.5 million Americans have Parkinson's disease, and some 60,000 new cases are diagnosed each year, according to the National Parkinson Foundation. Both men and women are affected in almost equal numbers.
Registration, including lunch, is $50 per person. Participants qualify for up to 7.0 category 1 continuing medical education credits. For information or to register, call 503 494-7772.